A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

Trial Information

A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

Inclusion Criteria:

- histologically confirmed nasopharyngeal carcinoma age of 18 years or over stage II ~
IVb no history of chemotherapy, radiotherapy, or immunotherapy for NPC with
measurable lesion based on RECIST 1.1 ECOG PS 0 ~2 good organ function (liver, renal,
hematologic)

Exclusion Criteria:

- active infectious disease requiring antibiotics uncontrolled heart disease pregnancy
and on feeding state history of other malignancy within 5 years before enrollment,
except for well treated non-melanomatous skin cancer, in situ cervical cancer,
thyroid cancer

NCT ID:

Start Date:

Completion Date:

Related Keywords:

Name

Location

We are a Cancer Social Network, Resource Directory & Education Hub supporting all those affected by cancer. knowcancer.com is intended to be solely for informational purposes and should not be a substitute for professional medical advice, diagnosis or treatment.